Literature DB >> 1376921

Random PCR mutagenesis screening of secreted proteins by direct expression in mammalian cells.

G C Rice1, D V Goeddel, G Cachianes, J Woronicz, E Y Chen, S R Williams, D W Leung.   

Abstract

We have developed a general method for screening randomly mutagenized expression libraries in mammalian cells by using fluorescence-activated cell sorting (FACS). The cDNA sequence of a secreted protein is randomly mutagenized by PCR under conditions of reduced Taq polymerase fidelity. The mutated DNA is inserted into an expression vector encoding the membrane glycophospholipid anchor sequence of decay-accelerating factor (DAF) fused to the C terminus of the secreted protein. This results in expression of the protein on the cell surface in transiently transfected mammalian cells, which can then be screened by FACS. This method was used to isolate mutants in the kringle 1 (K1) domain of tissue plasminogen activator (t-PA) that would no longer be recognized by a specific monoclonal antibody (mAb387) that inhibits binding of t-PA to its clearance receptor. DNA sequence analysis of the mutants and localization of the mutated residues on a three-dimensional model of the K1 domain identified three key discontinuous amino acid residues that are essential for mAb387 binding. Mutants with changes in any of these three residues were found to have reduced binding to the t-PA receptor on human hepatoma HepG2 cells but to retain full clot lysis activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376921      PMCID: PMC49313          DOI: 10.1073/pnas.89.12.5467

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2.

Authors:  D A Owensby; P A Morton; A L Schwartz
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

2.  Measurement of transient cDNA expression in mammalian cells using flow cytometric cell analysis and sorting.

Authors:  G C Rice; D Pennica; J A Borree; S R Williams
Journal:  Cytometry       Date:  1991

Review 3.  Tissue plasminogen activator: the biochemistry and pharmacology of variants produced by mutagenesis.

Authors:  D L Higgins; W F Bennett
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

Review 4.  Strategies and applications of in vitro mutagenesis.

Authors:  D Botstein; D Shortle
Journal:  Science       Date:  1985-09-20       Impact factor: 47.728

5.  Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2).

Authors:  A Peterson; B Seed
Journal:  Nature       Date:  1987 Oct 29-Nov 4       Impact factor: 49.962

6.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

7.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

8.  Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin.

Authors:  A Tulinsky; C H Park; B Mao; M Llinás
Journal:  Proteins       Date:  1988

9.  Catabolism of human tissue plasminogen activator in mice.

Authors:  H E Fuchs; H Berger; S V Pizzo
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

10.  Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological properties.

Authors:  N K Kalyan; S G Lee; J Wilhelm; K P Fu; W T Hum; R Rappaport; R W Hartzell; C Urbano; P P Hung
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

View more
  5 in total

1.  Functional interaction map of lyssavirus phosphoprotein: identification of the minimal transcription domains.

Authors:  Y Jacob; E Real; N Tordo
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Cell surface GPI-anchoring of CD45 isoforms.

Authors:  G B ten Dam; L G Poels; B Wieringa
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

3.  A genetic system to identify DNA polymerase beta mutator mutants.

Authors:  S L Washington; M S Yoon; A M Chagovetz; S X Li; C A Clairmont; B D Preston; K A Eckert; J B Sweasy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  The enzymatic basis for pesticide bioremediation.

Authors:  Colin Scott; Gunjan Pandey; Carol J Hartley; Colin J Jackson; Matthew J Cheesman; Matthew C Taylor; Rinku Pandey; Jeevan L Khurana; Mark Teese; Chris W Coppin; Kahli M Weir; Rakesh K Jain; Rup Lal; Robyn J Russell; John G Oakeshott
Journal:  Indian J Microbiol       Date:  2008-05-01       Impact factor: 2.461

5.  An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence.

Authors:  Brian M Taylor; J Scott Foulke; Robin Flinko; Alonso Heredia; Anthony DeVico; Marvin Reitz
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.